Screening for new agonists against Alzheimer's disease

被引:50
|
作者
Zheng, Huiqin
Wei, Dong-Qing
Zhang, Rui
Wang, Chunfang
Wei, Huachun
Chou, Kuo-Chen
机构
[1] Shanghai Jiao Tong Univ, Coll Life Sci & Technol, Shanghai 200240, Peoples R China
[2] Tianjin Normal Univ, Inst Bioinformat & Drug Discovery, Tianjin 300074, Peoples R China
[3] Gordon Life Sci Inst, San Diego, CA 92130 USA
关键词
Alzheimer's disease; alpha; 7; receptor; GTS-21; pharmacophore alignment; docking; traditional chinese medicines database;
D O I
10.2174/157340607781745492
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
To find new drug candidates for treating Alzheimer's disease, we used the similarity search technique and GTS-21 as a template to search the Traditional Chinese Medicines Database. The high-score molecules thus obtained were compared with the template through the flexible alignment. Those molecules which had good alignment with GTS-21 were selected for conducting the docking studies aimed at the alpha 7 nicotinic acetylcholine receptor. The CHARMM22 force field was taken to compute the partial charge and the TABU search was adopted to operate the docking process. The docking results thus obtained were used to compare with that of GTS-21. Those molecules which had better docking results than that of GTS-21 were singled out for further consideration. Finally, it was found through an in-depth structural analysis that Mol 7235 might be a promising candidate for further modification by experiments to make it become an effective drug for treating Alzheimer's disease.
引用
收藏
页码:488 / 493
页数:6
相关论文
共 50 条
  • [1] Identification of New Targets and the Virtual Screening of Lignans against Alzheimer's Disease
    Maia, Mayara dos Santos
    Soares Rodrigues, Gabriela Cristina
    de Sousa, Natalia Ferreira
    Scotti, Marcus Tullius
    Scotti, Luciana
    Mendonca-Junior, Francisco Jaime B.
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2020, 2020 (2020)
  • [2] Screening for Alzheimer's disease: A new telephone screening battery
    Lipton, RB
    Kuslansky, G
    Katz, M
    Sliwinski, M
    Stewart, WF
    Buschke, H
    NEUROLOGY, 1998, 50 (04) : A92 - A92
  • [3] PPARG AGONISTS IN ALZHEIMER'S DISEASE
    Heneka, M. T.
    JOURNAL OF NEUROCHEMISTRY, 2009, 110 : 219 - 219
  • [4] Muscarinic agonists in Alzheimer's disease
    Growdon, JH
    LIFE SCIENCES, 1997, 60 (13-14) : 993 - 998
  • [5] PPARγ agonists as new therapeutic agents for the treatment of Alzheimer's disease
    Landreth, Gary
    EXPERIMENTAL NEUROLOGY, 2006, 199 (02) : 245 - 248
  • [6] A new theory and new targets against Alzheimer's disease
    Xu, S.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2008, 56 (04) : S18 - S18
  • [7] A Template for New Drugs against Alzheimer's Disease
    Aguzzi, Adriano
    Gitler, Aaron D.
    CELL, 2013, 154 (06) : 1182 - 1184
  • [8] Screening of Common Potential Inhibitors against Periodontitis and Alzheimer's Disease
    Khan, Mahvish
    Khan, Saif
    Lohani, Mohtashim
    Alhobeira, Hazza A.
    Mirza, Shadab
    Haque, Shafiul
    JOURNAL OF PHARMACEUTICAL RESEARCH INTERNATIONAL, 2021, 33 (24B) : 83 - 91
  • [9] Computational screening for new neuroprotective ingredients against Alzheimer's disease from bilberry by cheminformatics approaches
    Xiao, Ran
    Liang, Rui
    Cai, Yun-hui
    Dong, Jie
    Zhang, Lin
    FRONTIERS IN NUTRITION, 2022, 9
  • [10] Screening for Alzheimer's disease
    Krause, A
    Jenkins, T
    SOUTH AFRICAN MEDICAL JOURNAL, 1997, 87 (02): : 128 - 130